Get the Stockscreener App
0.8702
4.69%
-0.0428
After Hours:
.87
-0.0002
-0.02%
BiomX Inc Stock (PHGE) Latest News
Microbiomes Market to Grow by USD 824.3 Million (2025-2029) with Rising Disease Prevalence Boosting the Market, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve
BiomX (NYSEAMERICAN:PHGE) Stock Price Down 1.3% – What’s Next? - Defense World
Barclays PLC Has $26,000 Position in BiomX Inc. (NYSEMKT:PHGE) - Defense World
Phage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight - GlobeNewswire Inc.
Barclays PLC Sells 225,000 Shares of BiomX Inc. (NYSEMKT:PHGE) - Defense World
HC Wainwright Reaffirms Buy Rating for BiomX (NYSEAMERICAN:PHGE) - Defense World
BiomX (NYSEMKT:PHGE) Stock Price Down 1.3% – Here’s Why - Defense World
BiomX Inc. Regains Compliance with NYSE American Listing Standards - Defense World
BiomX regains NYSE compliance - Investing.com
BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards - The Manila Times
BiomX Regains NYSE American Listing Compliance After Meeting All Standards - StockTitan
BiomX (NYSEAMERICAN:PHGE) Stock Price Down 12.2% – Should You Sell? - Defense World
BiomX (PHGE) 5-Day RSI : 13.43 (As of Nov. 20, 2024) - GuruFocus.com
BiomX Announces Third Quarter 2024 Financial Results and Clinical Program Updates - Defense World
Biomx stock plunges to 52-week low, hits $0.61 - Investing.com India
Biomx stock plunges to 52-week low, hits $0.61 By Investing.com - Investing.com Canada
BiomX shares hold Buy rating from H.C. Wainwright on Q3 results - Investing.com Canada
BiomX Inc. (AMEX:PHGE) Q3 2024 Earnings Call Transcript - Insider Monkey
BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net In - GuruFocus.com
BiomX Inc. Reports Q3 2024 Financial Turnaround - TipRanks
BiomX Inc (PHGE) Quarterly 10-Q Report - Quartzy
BiomX Inc (PHGE) Reports Q3 2024 Net Income of $9.6 Million Amid Increased R&D and Administrative Expenses - GuruFocus.com
BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates - The Manila Times
BiomX Completes Trial Enrollment, Reports $9.6M Net Income in Q3 Despite Program Delays | PHGE Stock News - StockTitan
Atopic Dermatitis Drugs Market to Grow by USD 6.2 Billion (2024-2028), Driven by High Prevalence of the Condition, AI-Powered Report Explores Market EvolutionTechnavio - Yahoo Finance
BiomX (NYSEMKT:PHGE) Trading 4.6% Higher – Time to Buy? - Defense World
BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024 - GlobeNewswire
Biomx stock plunges to 52-week low of $0.72 amid market challenges By Investing.com - Investing.com South Africa
Biomx stock plunges to 52-week low of $0.72 amid market challenges - Investing.com India
Biomx stock plunges to 52-week low, hits $0.87 - Investing.com India
Biomx stock plunges to 52-week low, hits $0.87 By Investing.com - Investing.com South Africa
BiomX (NYSEMKT:PHGE) Trading Down 2.3%Here's Why - MarketBeat
BiomX announces a mandatory unit separation - MSN
BiomX announces mandatory unit separation - Yahoo Finance
BiomX Announces a Mandatory Unit Separation - The Manila Times
BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising ... - Yahoo Finance
BiomX (NYSEAMERICAN:PHGE) Shares Down 1.5% – What’s Next? - Defense World
Biomx stock plunges to 52-week low, hitting $0.92 - Investing.com
Biomx stock plunges to 52-week low, hitting $0.92 By Investing.com - Investing.com South Africa
BiomX (NYSEMKT:PHGE) Stock Price Down 1% - Defense World
BiomX Shares Phage Therapy Advances and Vision - TipRanks
Bacteriophages Therapy Market Size, Share And Growth Analysis - openPR
BiomX Stock Gains From Favorable Study Data Presentation on BX004 - Yahoo Finance
BiomX to present data from Phase 1b/2a study of BX004 - TipRanks
BiomX to Provide Latest Update on Positive Phase 1b/2a - GlobeNewswire
BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference - StockTitan
Biomx stock plunges to 52-week low, hits $1.05 - Investing.com
BiomX (NYSEMKT:PHGE) Trading Down 5.4% - MarketBeat
BiomX (NYSEMKT:PHGE) Shares Down 5.4% - Defense World
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):